speb/financial-data huggingface dataset:
GSJ.MC income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.27
GSJ.MC balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 34472000.00
GSJ.MC balance_sheet (quarterly, 2025-06-30) — Total Assets: 1328799000.00
GSJ.MC balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 216087000.00
GSJ.MC balance_sheet (quarterly, 2025-06-30) — Total Debt: 12435000.00
GSJ.MC balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 249931000.00
GSJ.MC income_statement (quarterly, 2025-06-30) — Total Expenses: 373960000.00
GSJ.MC balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 1078868000.00
GSJ.MC balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 237098000.00
GSJ.MC balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 165938000.00
GSJ.MC balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 23918000.00
GSJ.MC income_statement (quarterly, 2025-06-30) — Total Unusual Items: -6891000.00
GSJ.MC income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -6891000.00
GSJ.MC balance_sheet (quarterly, 2025-06-30) — Work In Process: 12289000.00
GSJ.MC balance_sheet (quarterly, 2025-06-30) — Working Capital: 178771000.00
GSJ.MC income_statement (quarterly, 2025-06-30) — Write Off: 6277000.00
GSJ.MC income_statement (quarterly, 2025-09-30) — +Operating Expense: 90077000.00
GSJ.MC income_statement (quarterly, 2025-09-30) — +Total Revenue: 391953000.00
GSJ.MC balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 900856000.00
GSJ.MC balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 491738000.00
GSJ.MC balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 550709000.00
GSJ.MC balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 560395000.00
GSJ.MC balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 225813000.00
GSJ.MC income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 286221000.00
GSJ.MC balance_sheet (quarterly, 2025-09-30) — Current Assets: 1145005000.00
GSJ.MC balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 16918000.00
GSJ.MC balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 952753000.00
GSJ.MC balance_sheet (quarterly, 2025-09-30) — Current Provisions: 34979000.00
GSJ.MC income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 5800000.00
GSJ.MC income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 5800000.00
GSJ.MC income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 10779000.00
GSJ.MC income_statement (quarterly, 2025-09-30) — EBIT: 19583000.00
GSJ.MC income_statement (quarterly, 2025-09-30) — EBITDA: 25383000.00
GSJ.MC balance_sheet (quarterly, 2025-09-30) — Goodwill: 9984000.00
GSJ.MC balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 23535000.00
GSJ.MC income_statement (quarterly, 2025-09-30) — Gross Profit: 105732000.00
GSJ.MC balance_sheet (quarterly, 2025-09-30) — Inventory: 90374000.00
GSJ.MC balance_sheet (quarterly, 2025-09-30) — Invested Capital: 225813000.00
GSJ.MC balance_sheet (quarterly, 2025-09-30) — Investment Properties: 15189000.00
GSJ.MC balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 36912000.00
GSJ.MC balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 106140000.00
GSJ.MC balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 51437000.00
GSJ.MC balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 45560000.00
GSJ.MC balance_sheet (quarterly, 2025-09-30) — Minority Interest: 38005000.00
GSJ.MC income_statement (quarterly, 2025-09-30) — Net Income: 10779000.00
GSJ.MC income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 10779000.00
GSJ.MC income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 10173000.00
GSJ.MC income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 10779000.00
GSJ.MC income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 10779000.00
GSJ.MC income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 10173000.00
GSJ.MC income_statement (quarterly, 2025-09-30) — Net Interest Income: 431000.00
GSJ.MC income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 431000.00
GSJ.MC balance_sheet (quarterly, 2025-09-30) — Net PPE: 91319000.00
GSJ.MC balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 202278000.00
GSJ.MC balance_sheet (quarterly, 2025-09-30) — Non Current Accrued Expenses: 662000.00
GSJ.MC balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 19965000.00
GSJ.MC balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 14429000.00
GSJ.MC income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 27596000.00
GSJ.MC income_statement (quarterly, 2025-09-30) — Normalized Income: 12432654.25
GSJ.MC income_statement (quarterly, 2025-09-30) — Operating Income: 15655000.00
GSJ.MC income_statement (quarterly, 2025-09-30) — Operating Revenue: 391953000.00
GSJ.MC balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 65026083.00
GSJ.MC balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 13551000.00
GSJ.MC income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 37328000.00
GSJ.MC balance_sheet (quarterly, 2025-09-30) — Other Receivables: 2498000.00
GSJ.MC balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 9686000.00
GSJ.MC income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
GSJ.MC balance_sheet (quarterly, 2025-09-30) — Payables: 900856000.00
GSJ.MC income_statement (quarterly, 2025-09-30) — Pretax Income: 13614000.00
GSJ.MC income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 286221000.00
GSJ.MC income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 5800000.00
GSJ.MC balance_sheet (quarterly, 2025-09-30) — Share Issued: 65026083.00
GSJ.MC income_statement (quarterly, 2025-09-30) — Special Income Charges: -3288000.00
GSJ.MC balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 225813000.00
GSJ.MC balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 202278000.00
GSJ.MC income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -559345.75
GSJ.MC income_statement (quarterly, 2025-09-30) — Tax Provision: 3441000.00
GSJ.MC income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.25
GSJ.MC balance_sheet (quarterly, 2025-09-30) — Total Assets: 1383362000.00
GSJ.MC balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 225813000.00
GSJ.MC balance_sheet (quarterly, 2025-09-30) — Total Debt: 123058000.00
GSJ.MC balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 263818000.00
GSJ.MC income_statement (quarterly, 2025-09-30) — Total Expenses: 376298000.00
GSJ.MC balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 1119544000.00
GSJ.MC balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 238357000.00
GSJ.MC balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 166791000.00
GSJ.MC income_statement (quarterly, 2025-09-30) — Total Unusual Items: -2213000.00
GSJ.MC income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -2213000.00
GSJ.MC balance_sheet (quarterly, 2025-09-30) — Working Capital: 192252000.00
GSJ.MC income_statement (quarterly, 2025-09-30) — Write Off: 2797000.00
GSJ.MC income_statement (annual, 2025-12-31) — +Operating Expense: 367565000.00
GSJ.MC income_statement (quarterly, 2025-12-31) — +Operating Expense: 194006000.00
GSJ.MC income_statement (annual, 2025-12-31) — +Total Revenue: 1588131000.00
GSJ.MC income_statement (quarterly, 2025-12-31) — +Total Revenue: 831386000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Accounts Payable: 628192000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 628192000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Accounts Receivable: 357068000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 357068000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -79444000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -79444000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -22312000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -22312000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 20179000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 20179000.00
GSJ.MC income_statement (annual, 2025-12-31) — Basic Average Shares: 65026083.00
GSJ.MC income_statement (quarterly, 2025-12-31) — Basic Average Shares: 65026083.00
GSJ.MC income_statement (annual, 2025-12-31) — Basic EPS: 0.61
GSJ.MC income_statement (quarterly, 2025-12-31) — Basic EPS: 0.35
GSJ.MC cash_flow (annual, 2025-12-31) — Beginning Cash Position: 481106000.00
GSJ.MC cash_flow (annual, 2025-12-31) — Capital Expenditure: -7446000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 2013000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 2013000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Capital Stock: 1951000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Capital Stock: 1951000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 621588000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 621588000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 638547000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 638547000.00
GSJ.MC cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -11975000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Cash Equivalents: 144774000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Cash Equivalents: 144774000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Cash Financial: 476814000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Cash Financial: 476814000.00
GSJ.MC cash_flow (annual, 2025-12-31) — Change In Inventory: -9201000.00
GSJ.MC cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 0.00
GSJ.MC cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 0.00
GSJ.MC cash_flow (annual, 2025-12-31) — Change In Payable: 13964000.00
GSJ.MC cash_flow (annual, 2025-12-31) — Change In Receivables: 100593000.00
GSJ.MC cash_flow (annual, 2025-12-31) — Change In Working Capital: 105356000.00
GSJ.MC cash_flow (annual, 2025-12-31) — Changes In Cash: 144059000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Common Stock: 1951000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Common Stock: 1951000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Common Stock Equity: 247920000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 247920000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Construction In Progress: 63000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 63000.00
GSJ.MC income_statement (annual, 2025-12-31) — Cost Of Revenue: 1149829000.00
GSJ.MC income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 603965000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Current Assets: 1192261000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Current Assets: 1192261000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 760000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 760000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Current Debt: 7600000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Current Debt: 7600000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 8360000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 8360000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Current Deferred Taxes Liabilities: 0.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Current Deferred Taxes Liabilities: 0.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Current Liabilities: 964120000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 964120000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Current Provisions: 37594000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Current Provisions: 37594000.00
GSJ.MC cash_flow (annual, 2025-12-31) — Depreciation: 17680000.00
GSJ.MC cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 17680000.00
GSJ.MC income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 17680000.00
GSJ.MC income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 10752000.00
GSJ.MC income_statement (annual, 2025-12-31) — Depreciation Income Statement: 17680000.00
GSJ.MC income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 10752000.00
GSJ.MC income_statement (annual, 2025-12-31) — Diluted Average Shares: 65026083.00
GSJ.MC income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 65026083.00
GSJ.MC income_statement (annual, 2025-12-31) — Diluted EPS: 0.61
GSJ.MC income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.35
GSJ.MC income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 39851000.00
GSJ.MC income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 23044000.00
GSJ.MC cash_flow (annual, 2025-12-31) — Dividends Received Cfi: 5214000.00
GSJ.MC income_statement (annual, 2025-12-31) — EBIT: 62614000.00
GSJ.MC income_statement (quarterly, 2025-12-31) — EBIT: 39441000.00
GSJ.MC income_statement (annual, 2025-12-31) — EBITDA: 80294000.00
GSJ.MC income_statement (quarterly, 2025-12-31) — EBITDA: 50193000.00
GSJ.MC cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -3577000.00
GSJ.MC cash_flow (annual, 2025-12-31) — End Cash Position: 621588000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 14637000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 14637000.00
GSJ.MC cash_flow (annual, 2025-12-31) — Financing Cash Flow: -6980000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Finished Goods: 58595000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Finished Goods: 58595000.00
GSJ.MC cash_flow (annual, 2025-12-31) — Free Cash Flow: 152893000.00
GSJ.MC cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: 32000.00
GSJ.MC income_statement (annual, 2025-12-31) — General And Administrative Expense: 29963000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Goodwill: 9984000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Goodwill: 9984000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 23427000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 23427000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 379380000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 379380000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Gross PPE: 174330000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Gross PPE: 174330000.00
GSJ.MC income_statement (annual, 2025-12-31) — Gross Profit: 438302000.00
GSJ.MC income_statement (quarterly, 2025-12-31) — Gross Profit: 227421000.00
GSJ.MC income_statement (annual, 2025-12-31) — Interest Expense: 3108000.00
GSJ.MC income_statement (quarterly, 2025-12-31) — Interest Expense: 4706000.00
GSJ.MC income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 3108000.00
GSJ.MC income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 4706000.00
GSJ.MC income_statement (annual, 2025-12-31) — Interest Income: 12492000.00
GSJ.MC income_statement (quarterly, 2025-12-31) — Interest Income: 6745000.00
GSJ.MC income_statement (annual, 2025-12-31) — Interest Income Non Operating: 12492000.00
GSJ.MC income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 6745000.00
GSJ.MC cash_flow (annual, 2025-12-31) — Interest Paid Cff: -5077000.00
GSJ.MC cash_flow (annual, 2025-12-31) — Interest Received Cfi: 13622000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Inventory: 82483000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Inventory: 82483000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Invested Capital: 264000000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Invested Capital: 264000000.00
GSJ.MC cash_flow (annual, 2025-12-31) — Investing Cash Flow: -9300000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Investment Properties: 14941000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Investment Properties: 14941000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 34816000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 34816000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Investmentsin Associatesat Cost: 54905000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Investmentsin Associatesat Cost: 54905000.00
GSJ.MC cash_flow (annual, 2025-12-31) — Issuance Of Debt: 9403000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 1253000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 1253000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Long Term Debt: 8480000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 8480000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 9733000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 9733000.00
GSJ.MC cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 9403000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 54905000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 54905000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Long Term Provisions: 48654000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 48654000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 62742000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 62742000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Minority Interest: 39903000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Minority Interest: 39903000.00
GSJ.MC income_statement (annual, 2025-12-31) — Minority Interests: -997000.00
GSJ.MC income_statement (quarterly, 2025-12-31) — Minority Interests: -391000.00
GSJ.MC cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 11269000.00
GSJ.MC income_statement (annual, 2025-12-31) — Net Income: 39851000.00
GSJ.MC income_statement (quarterly, 2025-12-31) — Net Income: 23044000.00
GSJ.MC income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 39851000.00
GSJ.MC income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 23044000.00
GSJ.MC income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 40848000.00
GSJ.MC income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 23435000.00
GSJ.MC income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 39851000.00
GSJ.MC income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 23044000.00
GSJ.MC income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 39851000.00
GSJ.MC income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 23044000.00
GSJ.MC cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 59506000.00
GSJ.MC income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 40848000.00
GSJ.MC income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 23435000.00
GSJ.MC cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -526000.00
GSJ.MC income_statement (annual, 2025-12-31) — Net Interest Income: 5118000.00
GSJ.MC income_statement (quarterly, 2025-12-31) — Net Interest Income: 2039000.00
GSJ.MC cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -16559000.00
GSJ.MC cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 7550000.00
GSJ.MC cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 9403000.00
GSJ.MC income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 5118000.00
GSJ.MC income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 2039000.00
GSJ.MC cash_flow (annual, 2025-12-31) — Net Other Financing Charges: 2522000.00
GSJ.MC cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -5222000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Net PPE: 94886000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Net PPE: 94886000.00
GSJ.MC cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -5829000.00
GSJ.MC cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: -1853000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 224493000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 224493000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Non Current Accrued Expenses: 654000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Non Current Accrued Expenses: 654000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 17050000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 17050000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 14412000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 14412000.00
GSJ.MC income_statement (annual, 2025-12-31) — Normalized EBITDA: 95613000.00
GSJ.MC income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 52068000.00
GSJ.MC income_statement (annual, 2025-12-31) — Normalized Income: 50366754.92
GSJ.MC income_statement (quarterly, 2025-12-31) — Normalized Income: 24309024.47
GSJ.MC cash_flow (annual, 2025-12-31) — Operating Cash Flow: 160339000.00
GSJ.MC income_statement (annual, 2025-12-31) — Operating Income: 70737000.00
GSJ.MC income_statement (quarterly, 2025-12-31) — Operating Income: 33415000.00
GSJ.MC income_statement (annual, 2025-12-31) — Operating Revenue: 1588131000.00
GSJ.MC income_statement (quarterly, 2025-12-31) — Operating Revenue: 831386000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 65026083.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 65026083.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Other Current Liabilities: -18000000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: -18000000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Other Equity Interest: 22000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: 22000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 13443000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 13443000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Other Inventories: 8426000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Other Inventories: 8426000.00
GSJ.MC cash_flow (annual, 2025-12-31) — Other Non Cash Items: -24458000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 18000000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 18000000.00
GSJ.MC income_statement (annual, 2025-12-31) — Other Operating Expenses: 66539000.00
GSJ.MC income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 75216000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Other Payable: 15427000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Other Payable: 15427000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Other Properties: 31935000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Other Properties: 31935000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Other Receivables: 71205000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Other Receivables: 71205000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 16959000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 16959000.00
GSJ.MC income_statement (annual, 2025-12-31) — Other Special Charges: 533000.00
GSJ.MC income_statement (quarterly, 2025-12-31) — Other Special Charges: 1101000.00
GSJ.MC income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
GSJ.MC income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Payables: 671492000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Payables: 671492000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Prepaid Assets: 9095000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 9095000.00
GSJ.MC income_statement (annual, 2025-12-31) — Pretax Income: 59506000.00
GSJ.MC income_statement (quarterly, 2025-12-31) — Pretax Income: 34735000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Properties: 79590000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Properties: 79590000.00
GSJ.MC cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 11471000.00
GSJ.MC cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -526000.00
GSJ.MC cash_flow (annual, 2025-12-31) — Purchase Of Investment: -16559000.00
GSJ.MC cash_flow (annual, 2025-12-31) — Purchase Of PPE: -6920000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Raw Materials: 2029000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Raw Materials: 2029000.00
GSJ.MC income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 1149829000.00
GSJ.MC income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 603965000.00
GSJ.MC income_statement (annual, 2025-12-31) — Reconciled Depreciation: 17680000.00
GSJ.MC income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 10752000.00
GSJ.MC income_statement (annual, 2025-12-31) — Rent And Landing Fees: 41745000.00
GSJ.MC income_statement (annual, 2025-12-31) — Rent Expense Supplemental: 41745000.00
GSJ.MC cash_flow (annual, 2025-12-31) — Repayment Of Debt: -1853000.00
GSJ.MC income_statement (annual, 2025-12-31) — Research And Development: 5000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Retained Earnings: 39851000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 39851000.00
GSJ.MC cash_flow (annual, 2025-12-31) — Sale Of Intangibles: 0.00
GSJ.MC cash_flow (annual, 2025-12-31) — Sale Of Investment: 0.00
GSJ.MC cash_flow (annual, 2025-12-31) — Sale Of PPE: 1091000.00
GSJ.MC income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 5978000.00
GSJ.MC income_statement (annual, 2025-12-31) — Selling General And Administration: 35941000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Share Issued: 65026083.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Share Issued: 65026083.00
GSJ.MC cash_flow (annual, 2025-12-31) — Short Term Debt Payments: -1853000.00
GSJ.MC income_statement (annual, 2025-12-31) — Special Income Charges: -15287000.00
GSJ.MC income_statement (quarterly, 2025-12-31) — Special Income Charges: -1861000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Stockholders Equity: 247920000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 247920000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Tangible Book Value: 224493000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 224493000.00
GSJ.MC income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -4803245.08
GSJ.MC income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -609975.53
GSJ.MC income_statement (annual, 2025-12-31) — Tax Provision: 18658000.00
GSJ.MC income_statement (quarterly, 2025-12-31) — Tax Provision: 11300000.00
GSJ.MC income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.31
GSJ.MC income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.33
GSJ.MC balance_sheet (annual, 2025-12-31) — Taxes Receivable: 33863000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 33863000.00
GSJ.MC cash_flow (annual, 2025-12-31) — Taxes Refund Paid: -19939000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Total Assets: 1432286000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Total Assets: 1432286000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Total Capitalization: 256400000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 256400000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Total Debt: 18093000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Total Debt: 18093000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 287823000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 287823000.00
GSJ.MC income_statement (annual, 2025-12-31) — Total Expenses: 1517394000.00
GSJ.MC income_statement (quarterly, 2025-12-31) — Total Expenses: 797971000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 1144463000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 1144463000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 240025000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 240025000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 180343000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 180343000.00
GSJ.MC income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 32314000.00
GSJ.MC income_statement (annual, 2025-12-31) — Total Other Finance Cost: 4266000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Total Tax Payable: 27873000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 27873000.00
GSJ.MC income_statement (annual, 2025-12-31) — Total Unusual Items: -15319000.00
GSJ.MC income_statement (quarterly, 2025-12-31) — Total Unusual Items: -1875000.00
GSJ.MC income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -15319000.00
GSJ.MC income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -1875000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Work In Process: 13433000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Work In Process: 13433000.00
GSJ.MC balance_sheet (annual, 2025-12-31) — Working Capital: 228141000.00
GSJ.MC balance_sheet (quarterly, 2025-12-31) — Working Capital: 228141000.00
GSJ.MC income_statement (annual, 2025-12-31) — Write Off: 14754000.00
GSJ.MC income_statement (quarterly, 2025-12-31) — Write Off: 760000.00
GSJ.MC income_statement (quarterly, 2026-03-31) — +Operating Expense: 100926000.00
GSJ.MC income_statement (quarterly, 2026-03-31) — +Total Revenue: 417320000.00
GSJ.MC balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 922320000.00
GSJ.MC balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 474266000.00
GSJ.MC balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 39146000.00
GSJ.MC income_statement (quarterly, 2026-03-31) — Basic Average Shares: 65026083.00
GSJ.MC income_statement (quarterly, 2026-03-31) — Basic EPS: 0.19
GSJ.MC balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 642426000.00
GSJ.MC balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 658782000.00
GSJ.MC balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 265404000.00
GSJ.MC income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 298385000.00
GSJ.MC balance_sheet (quarterly, 2026-03-31) — Current Assets: 1232084000.00
GSJ.MC balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 19391000.00
GSJ.MC balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 979484000.00
GSJ.MC balance_sheet (quarterly, 2026-03-31) — Current Provisions: 37773000.00
GSJ.MC income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 4710000.00
GSJ.MC income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 4710000.00
GSJ.MC income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 65026083.00
GSJ.MC income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.19
GSJ.MC income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 12546000.00
GSJ.MC income_statement (quarterly, 2026-03-31) — EBIT: 18009000.00
GSJ.MC income_statement (quarterly, 2026-03-31) — EBITDA: 22719000.00
GSJ.MC balance_sheet (quarterly, 2026-03-31) — Goodwill: 9984000.00
GSJ.MC balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 23305000.00
GSJ.MC balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 474266000.00
GSJ.MC income_statement (quarterly, 2026-03-31) — Gross Profit: 118935000.00
GSJ.MC balance_sheet (quarterly, 2026-03-31) — Inventory: 95562000.00
GSJ.MC balance_sheet (quarterly, 2026-03-31) — Invested Capital: 265404000.00
GSJ.MC balance_sheet (quarterly, 2026-03-31) — Investment Properties: 16304000.00
GSJ.MC balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 39146000.00
GSJ.MC balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 124405000.00
GSJ.MC balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 54675000.00
GSJ.MC balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 49804000.00
GSJ.MC balance_sheet (quarterly, 2026-03-31) — Minority Interest: 40462000.00
GSJ.MC income_statement (quarterly, 2026-03-31) — Net Income: 12546000.00
GSJ.MC income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 12546000.00
GSJ.MC income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 12546000.00
GSJ.MC income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 12546000.00
GSJ.MC income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 12546000.00
GSJ.MC income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 12546000.00
GSJ.MC income_statement (quarterly, 2026-03-31) — Net Interest Income: 1240000.00
GSJ.MC income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 1240000.00
GSJ.MC balance_sheet (quarterly, 2026-03-31) — Net PPE: 95627000.00
GSJ.MC balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 242099000.00
GSJ.MC balance_sheet (quarterly, 2026-03-31) — Non Current Accrued Expenses: 633000.00
GSJ.MC balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 16736000.00
GSJ.MC balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 17685000.00
GSJ.MC income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 22607000.00
GSJ.MC income_statement (quarterly, 2026-03-31) — Normalized Income: 12467534.96
GSJ.MC income_statement (quarterly, 2026-03-31) — Operating Income: 18009000.00
GSJ.MC income_statement (quarterly, 2026-03-31) — Operating Revenue: 417320000.00
GSJ.MC balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 65026083.00
GSJ.MC balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 13321000.00
GSJ.MC income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 42358000.00
GSJ.MC balance_sheet (quarterly, 2026-03-31) — Other Receivables: 3474000.00
GSJ.MC balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 16356000.00
GSJ.MC income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
GSJ.MC balance_sheet (quarterly, 2026-03-31) — Payables: 922320000.00
GSJ.MC income_statement (quarterly, 2026-03-31) — Pretax Income: 17908000.00
GSJ.MC income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 298385000.00
GSJ.MC income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 4710000.00
GSJ.MC balance_sheet (quarterly, 2026-03-31) — Share Issued: 65026083.00
GSJ.MC income_statement (quarterly, 2026-03-31) — Special Income Charges: 112000.00
GSJ.MC balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 265404000.00
GSJ.MC balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 242099000.00
GSJ.MC income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 33534.96
GSJ.MC income_statement (quarterly, 2026-03-31) — Tax Provision: 5362000.00
GSJ.MC income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.30
GSJ.MC balance_sheet (quarterly, 2026-03-31) — Total Assets: 1477877000.00
GSJ.MC balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 265404000.00
GSJ.MC balance_sheet (quarterly, 2026-03-31) — Total Debt: 143796000.00
GSJ.MC balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 305866000.00
GSJ.MC income_statement (quarterly, 2026-03-31) — Total Expenses: 399311000.00
GSJ.MC balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 1172011000.00
GSJ.MC balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 245793000.00
GSJ.MC balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 192527000.00
GSJ.MC income_statement (quarterly, 2026-03-31) — Total Unusual Items: 112000.00
GSJ.MC income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 112000.00
GSJ.MC balance_sheet (quarterly, 2026-03-31) — Working Capital: 252600000.00
GSJ.MC income_statement (quarterly, 2026-03-31) — Write Off: -112000.00
GSK balance_sheet (annual, 2021-12-31) — Allowance For Doubtful Accounts Receivable: -150000000.00
GSK balance_sheet (annual, 2021-12-31) — Derivative Product Liabilities: 1000000.00
GSK cash_flow (annual, 2021-12-31) — Gain Loss On Investment Securities: -8000000.00
GSK income_statement (annual, 2021-12-31) — Net Income Discontinuous Operations: 1580000000.00
GSK cash_flow (annual, 2021-12-31) — Net Other Investing Changes: -122000000.00
GSK income_statement (annual, 2021-12-31) — Rent Expense Supplemental: 20000000.00
GSK cash_flow (annual, 2021-12-31) — Sale Of Investment: 18000000.00
GSK income_statement (annual, 2022-12-31) — +Operating Expense: 13041000000.00
GSK income_statement (annual, 2022-12-31) — +Total Revenue: 29324000000.00
GSK balance_sheet (annual, 2022-12-31) — Accounts Payable: 3866000000.00
GSK balance_sheet (annual, 2022-12-31) — Accounts Receivable: 5452000000.00
GSK balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -10518000000.00
GSK balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 3440000000.00
GSK balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -91000000.00
GSK cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 1086000000.00
GSK balance_sheet (annual, 2022-12-31) — Assets Held For Sale Current: 98000000.00
GSK balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 1174000000.00
GSK income_statement (annual, 2022-12-31) — Basic Average Shares: 2013000000.00
GSK income_statement (annual, 2022-12-31) — Basic EPS: 7.43
GSK cash_flow (annual, 2022-12-31) — Beginning Cash Position: 3819000000.00
GSK balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 561000000.00
GSK cash_flow (annual, 2022-12-31) — Capital Expenditure: -2258000000.00
GSK balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 1008000000.00
GSK balance_sheet (annual, 2022-12-31) — Capital Stock: 1347000000.00
GSK balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 3523000000.00
GSK balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 7677000000.00
GSK cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -3467000000.00
GSK cash_flow (annual, 2022-12-31) — Change In Inventory: -269000000.00
GSK cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -962000000.00
GSK cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 1628000000.00
GSK cash_flow (annual, 2022-12-31) — Change In Payable: 489000000.00
GSK cash_flow (annual, 2022-12-31) — Change In Receivables: -616000000.00
GSK cash_flow (annual, 2022-12-31) — Change In Working Capital: 270000000.00
GSK cash_flow (annual, 2022-12-31) — Changes In Cash: -546000000.00
GSK balance_sheet (annual, 2022-12-31) — Common Stock: 1347000000.00
GSK cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -3467000000.00
GSK balance_sheet (annual, 2022-12-31) — Common Stock Equity: 10598000000.00
GSK cash_flow (annual, 2022-12-31) — Common Stock Issuance: 25000000.00
GSK balance_sheet (annual, 2022-12-31) — Construction In Progress: 1850000000.00
GSK income_statement (annual, 2022-12-31) — Cost Of Revenue: 9554000000.00
GSK balance_sheet (annual, 2022-12-31) — Current Assets: 20769000000.00
GSK balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 167000000.00
GSK balance_sheet (annual, 2022-12-31) — Current Debt: 3785000000.00
GSK balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 3952000000.00
GSK balance_sheet (annual, 2022-12-31) — Current Liabilities: 22810000000.00
GSK balance_sheet (annual, 2022-12-31) — Current Provisions: 652000000.00
GSK cash_flow (annual, 2022-12-31) — Deferred Tax: 707000000.00
GSK balance_sheet (annual, 2022-12-31) — Defined Pension Benefit: 229000000.00
GSK cash_flow (annual, 2022-12-31) — Depreciation: 1061000000.00
GSK cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 2147000000.00
GSK balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 0.00
GSK income_statement (annual, 2022-12-31) — Diluted Average Shares: 2042000000.00
GSK income_statement (annual, 2022-12-31) — Diluted EPS: 7.32
GSK income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 14956000000.00
GSK cash_flow (annual, 2022-12-31) — Dividends Received Cfi: 6000000.00
GSK income_statement (annual, 2022-12-31) — EBIT: 6454000000.00
GSK income_statement (annual, 2022-12-31) — EBITDA: 8601000000.00
GSK cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 152000000.00
GSK cash_flow (annual, 2022-12-31) — End Cash Position: 3425000000.00
GSK balance_sheet (annual, 2022-12-31) — Financial Assets: 0.00
GSK balance_sheet (annual, 2022-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 327000000.00
GSK cash_flow (annual, 2022-12-31) — Financing Cash Flow: 823000000.00
GSK balance_sheet (annual, 2022-12-31) — Finished Goods: 1284000000.00
GSK cash_flow (annual, 2022-12-31) — Free Cash Flow: 5145000000.00
GSK cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: -1000000.00
GSK cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: -36000000.00
GSK cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: -185000000.00
GSK income_statement (annual, 2022-12-31) — General And Administrative Expense: 8372000000.00
GSK balance_sheet (annual, 2022-12-31) — Goodwill: 7046000000.00
GSK balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 21364000000.00
GSK balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 5543000000.00
GSK balance_sheet (annual, 2022-12-31) — Gross PPE: 20138000000.00
GSK income_statement (annual, 2022-12-31) — Gross Profit: 19770000000.00
GSK balance_sheet (annual, 2022-12-31) — Hedging Assets Current: 190000000.00
GSK income_statement (annual, 2022-12-31) — Interest Expense: 826000000.00
GSK income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 826000000.00
GSK income_statement (annual, 2022-12-31) — Interest Income: 31000000.00
GSK income_statement (annual, 2022-12-31) — Interest Income Non Operating: 31000000.00
GSK cash_flow (annual, 2022-12-31) — Interest Paid Cff: -848000000.00
GSK cash_flow (annual, 2022-12-31) — Interest Received Cfi: 64000000.00
GSK balance_sheet (annual, 2022-12-31) — Inventory: 5146000000.00
GSK balance_sheet (annual, 2022-12-31) — Invested Capital: 30577000000.00
GSK cash_flow (annual, 2022-12-31) — Investing Cash Flow: -8772000000.00
GSK balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 1501000000.00
GSK balance_sheet (annual, 2022-12-31) — Investmentsin Associatesat Cost: 64000000.00
GSK balance_sheet (annual, 2022-12-31) — Investmentsin Joint Venturesat Cost: 10000000.00
GSK cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 25000000.00
GSK cash_flow (annual, 2022-12-31) — Issuance Of Debt: 2046000000.00
GSK balance_sheet (annual, 2022-12-31) — Land And Improvements: 6648000000.00
GSK balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 841000000.00
GSK balance_sheet (annual, 2022-12-31) — Long Term Debt: 16194000000.00
GSK balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 17035000000.00
GSK cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 1025000000.00
GSK cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -6668000000.00
GSK balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 74000000.00
GSK balance_sheet (annual, 2022-12-31) — Long Term Provisions: 532000000.00
GSK balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 11073000000.00
GSK balance_sheet (annual, 2022-12-31) — Minority Interest: -502000000.00
GSK income_statement (annual, 2022-12-31) — Minority Interests: -665000000.00
GSK cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -3136000000.00
GSK cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 25000000.00
GSK balance_sheet (annual, 2022-12-31) — Net Debt: 16456000000.00
GSK income_statement (annual, 2022-12-31) — Net Income: 14956000000.00
GSK income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 14956000000.00
GSK income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 4921000000.00
GSK income_statement (annual, 2022-12-31) — Net Income Discontinuous Operations: 10700000000.00
GSK income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 14956000000.00
GSK income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 4256000000.00
GSK cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 4921000000.00
GSK income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 15621000000.00
GSK cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -919000000.00
GSK income_statement (annual, 2022-12-31) — Net Interest Income: -826000000.00
GSK cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 1000000.00
GSK cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -4622000000.00
GSK cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -5643000000.00
GSK income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -826000000.00
GSK cash_flow (annual, 2022-12-31) — Net Other Financing Charges: 10458000000.00
GSK cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -3791000000.00
GSK balance_sheet (annual, 2022-12-31) — Net PPE: 9620000000.00
GSK cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -997000000.00
GSK cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 1021000000.00
GSK balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -10766000000.00
GSK balance_sheet (annual, 2022-12-31) — Non Current Accrued Expenses: 11000000.00
GSK balance_sheet (annual, 2022-12-31) — Non Current Deferred Revenue: 83000000.00
GSK balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 5658000000.00
GSK balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 289000000.00
GSK balance_sheet (annual, 2022-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 2579000000.00
GSK income_statement (annual, 2022-12-31) — Normalized EBITDA: 8874000000.00
GSK income_statement (annual, 2022-12-31) — Normalized Income: 4494602000.00
GSK cash_flow (annual, 2022-12-31) — Operating Cash Flow: 7403000000.00
GSK income_statement (annual, 2022-12-31) — Operating Income: 6729000000.00
GSK income_statement (annual, 2022-12-31) — Operating Revenue: 29324000000.00
GSK balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 4094218581.00
GSK balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 1289000000.00
GSK balance_sheet (annual, 2022-12-31) — Other Equity Interest: -353000000.00